BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 10893910)

  • 1. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse prevention program content: systematizing the classification of what programs target for change.
    Hansen WB; Dusenbury L; Bishop D; Derzon JH
    Health Educ Res; 2007 Jun; 22(3):351-60. PubMed ID: 16963725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring sustainment of prevention programs and initiatives: a study protocol.
    Palinkas LA; Spear SE; Mendon SJ; Villamar J; Valente T; Chou CP; Landsverk J; Kellam SG; Brown CH
    Implement Sci; 2016 Jul; 11():95. PubMed ID: 27422149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focusing on customer service.
    Management Sciences for Health MSH. Family Planning Management Development
    Fam Plan Manag; 1996; 5(1):1-18. PubMed ID: 12320174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance contracting for substance abuse treatment.
    Commons M; McGuire TG; Riordan MH
    Health Serv Res; 1997 Dec; 32(5):631-50. PubMed ID: 9402905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical assistance as a prevention capacity-building tool: a demonstration using the getting to outcomes framework.
    Hunter SB; Chinman M; Ebener P; Imm P; Wandersman A; Ryan GW
    Health Educ Behav; 2009 Oct; 36(5):810-28. PubMed ID: 19176468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithms for resource allocation of substance abuse prevention funds based on social indicators: a case study on state of Florida--Part 3.
    Kim S; Wurster L; Williams C; Hepler N
    J Drug Educ; 1998; 28(4):283-306. PubMed ID: 10097481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for monitoring social process and outcomes in environmental programs.
    Chapman S
    Eval Program Plann; 2014 Dec; 47():45-53. PubMed ID: 25128755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of client-provider interactions: a review of methodological issues.
    Simmons R; Elias C
    Stud Fam Plann; 1994; 25(1):1-17. PubMed ID: 8209391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program.
    Merrill JC; Pinsky I; Killeya-Jones LA; Sloboda Z; Dilascio T
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():25. PubMed ID: 16956400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The administrative control system of substance abuse managed care.
    Sosin MR
    Health Serv Res; 2005 Feb; 40(1):157-76. PubMed ID: 15663707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting science-based prevention in communities.
    Hawkins JD; Catalano RF; Arthur MW
    Addict Behav; 2002; 27(6):951-76. PubMed ID: 12369478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care.
    Bernstein E; Topp D; Shaw E; Girard C; Pressman K; Woolcock E; Bernstein J
    Acad Emerg Med; 2009 Nov; 16(11):1225-33. PubMed ID: 20053242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.